Repro Med Systems Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +131.8% | -117.3% | – | +64.4% | -78.3% | -331.8% | – | – | – | – | – | |
| – | -4.3% | +10.7% | +2.7% | +0.2% | +10.0% | +23.0% | +10.6% | +26.8% | +48.2% | +2.1% | -8.8% | |
| – | +43.6% | +79.4% | -36.9% | +182.3% | +229.1% | +34.4% | +67.3% | +13.7% | -10.1% | -5.2% | +3.4% | |
| – | – | – | -30.4% | +162.7% | +248.5% | +210.3% | -70.2% | +18.3% | – | – | – | |
| – | – | -128.7% | – | – | – | – | – | – | -14.2% | +64.0% | -116.2% | |
| – | -72.9% | +105.8% | -47.4% | +120.4% | -11.6% | +149.4% | -64.6% | +646.6% | -70.9% | +59.3% | -28.1% | |
| – | -74.6% | +119.7% | -47.3% | +688.9% | – | -179.1% | -64.7% | +665.1% | -70.9% | +63.6% | -28.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +231.9% | +74.7% | -86.2% | +90.2% | -92.3% | +123,990.7% | -100.0% | – | – | – | – | |
| – | – | – | +0.0% | +0.0% | +0.0% | +10.7% | – | -125.1% | +72.1% | -30.9% | +151.4% | |
| – | -132.4% | +74.7% | -86.2% | – | +3,374.2% | +4,532.7% | -88.4% | -89.7% | -178.3% | +13.6% | -10.9% | |
| – | +398.6% | -154.0% | – | – | – | +905.8% | -109.2% | – | – | – | – | |
| – | +1,981.1% | -143.6% | – | +46.5% | -110.5% | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.